Polyunsaturated Fatty Acids Supplementation and Blood Metabolome

March 26, 2019 updated by: Poznan University of Life Sciences

Analysis of the Effect of a Diet Enriched With Polyunsaturated Fatty Acids on the Proteomic and Metabolomic Profiles of Blood Plasma of Healthy People Aged 18-50

Analysis of the effect of dietary intervention based on increased polyunsaturated fatty acid intake on health. Specifically changes in blood lipid profile, as well as proteomic and metabolomic profiles of healthy adults will be analyzed.

Study Overview

Status

Unknown

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Poznań, Poland
        • Recruiting
        • Poznan University of Life Sciences
        • Contact:
          • Agata Chmurzynska

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • good health,
  • proper body weight
  • not meeting the needs for polyunsaturated fatty acids

Exclusion Criteria:

  • increased body weight,
  • limited communication to an extent that makes it impossible to carry out a food interview,
  • eating disorders (according to food history),
  • metabolic diseases,
  • pregnancy,
  • lactation,
  • taking drugs that influence the metabolism of lipids or carbohydrates

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: BASIC_SCIENCE
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: The high PUFA diet group
This will receive detailed nutritional recommendations and will consume at least 4 table spoons of olive oil or 30 grams of nuts daily for 12 weeks.
Assumptions of nutritional intervention: in a randomized manner volunteers will be assigned to one of two groups: a control group which will receive general nutritional recommendations, based on the Polish nutrition pyramid, and the intervention group which will receive nutritional recommendations, based on the Polish nutrition pyramid and will consume at least 4 tablespoons of olive oil or 30 grams of nuts every day for 12 weeks.
NO_INTERVENTION: Control group
The Control group will receive general nutritional recommendations based on Human Nutrition Recommendations for Polish Population.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutrient intake
Time Frame: 12 weeks
Nutrient intake (3-day food records)
12 weeks
Concentrations of lipoproteins and glucose
Time Frame: 12 weeks
Serum concentrations of lipoproteins and glucose at baseline and after the intervention [mg/dl]
12 weeks
Proteomic analysis of plasma
Time Frame: 12 weeks
The aim is to identify biomarkers in the blood and to determine the differences between people from the control and the intervention group
12 weeks
Metabolite concentrations in plasma
Time Frame: 12 weeks
Metabolite concentrations in plasma samples are measured by high resolution mass spectrometry at baseline and after the intervention
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body mass
Time Frame: 12 weeks
body mass at baseline and after the intervention
12 weeks
Height
Time Frame: 12 weeks
height
12 weeks
Percentage body fat
Time Frame: 12 weeks
percentage body fat at baseline and after the intervention
12 weeks
Waist circumference
Time Frame: 12 weeks
waist circumference at baseline and after the intervention
12 weeks
hip circumference
Time Frame: 12 weeks
hip circumference at baseline and after the intervention
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Agata Chmurzynska, PhD, Poznan University of Life Sciences

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2019

Primary Completion (ANTICIPATED)

April 1, 2019

Study Completion (ANTICIPATED)

June 1, 2019

Study Registration Dates

First Submitted

February 21, 2019

First Submitted That Met QC Criteria

March 26, 2019

First Posted (ACTUAL)

March 27, 2019

Study Record Updates

Last Update Posted (ACTUAL)

March 27, 2019

Last Update Submitted That Met QC Criteria

March 26, 2019

Last Verified

March 1, 2019

More Information

Terms related to this study

Other Study ID Numbers

  • LKB 1249/19

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy

Clinical Trials on The high PUFA diet group

Subscribe